Migraine IV therapy in the context of broader wellness Migraine is a neurological condition, not simply a bad headache, and effective long-term management usually requires more than acute interventions alone
There is not yet a direct evidence base for a universal strategy of treating all healthy adults to apoB below 0.6 g/L or lower
Strategies such as gradual ascent, preacclimatization, descent, and several pharmacological agents (e.g., acetazolamide, methazolamide, dexamethasone, nifedipine, and sildenafil) are widely accepted as effective strategies for preventing and treating acute altitude illnesses
L.NavasP.et al
Neither BPC-157 nor TB-500/thymosin beta-4 is approved by the FDA for any human therapeutic use , and neither is an approved treatment for any neurological condition
Conversely, transgenic mice with CGRP overexpression in osteoblasts showed higher trabecular bone density, confirming the positive relationship between CGRP signaling and bone mass